Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have ...
The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.
Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
A phase 3 trial finds pritelivir significantly improves cure rates for immunocompromised individuals with refractory HSV infections.
Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with ...
Herpes is one of the most common viral infections in the world, yet it remains widely misunderstood. Caused by the herpes ...
Defects in a single protein involved in cell death may impair the immune system's ability to combat a herpes viral infection in the central nervous system, scientists have found in new research that ...
Medical researchers found a new way genetics influences the body's antiviral response by studying a life-threatening disease caused by a common virus: herpes simplex virus 1 (HSV-1). A collaboration ...
Please provide your email address to receive an email when new articles are posted on . The myriad manifestations of herpes simplex keratitis can be difficult to diagnose without a high suspicion, but ...
Cold sores are common infections in children. They’re also called fever blisters, oral herpes, or herpes labialis. Despite their name, cold sores don’t have anything to do with colds. Cold sores are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results